David Lockley
About David Lockley
David Lockley is the Product Defence and Toxicology Manager at Venator Materials Plc, where he has worked since 2017. He holds multiple degrees in toxicology and has extensive experience in the field, contributing to industry-wide initiatives focused on human health research and risk assessment.
Work at Venator Materials
David Lockley has been employed at Venator Materials Plc since 2017, serving as the Product Defence and Toxicology Manager within the Global Product EHS department. His role involves providing toxicological expertise and ensuring compliance with health and safety regulations. He works from the company's location in Wynyard, Stockton-on-Tees, United Kingdom. His responsibilities include leading initiatives related to human health research and risk assessment.
Education and Expertise
David Lockley has an extensive educational background in toxicology and related fields. He earned a PhD in Biochemical Toxicology from the University of Newcastle-upon-Tyne between 1996 and 2000. He also holds an MSc in Toxicology from The University of Birmingham, completed in 1996. Additionally, he achieved a Postgraduate Certificate in REACH Management from The University of Hull in 2008. He is a Eurotox Registered Toxicologist and has been involved in toxicological studies since 2008.
Background
David Lockley began his career in the field of toxicology and product safety after completing his education. He has held various positions in reputable organizations, including GlaxoSmithKline, Unilever, and AstraZeneca. His career spans several years, with roles that have focused on toxicology, regulatory compliance, and product safety management. He has also contributed to industry-wide trade associations and task forces.
Achievements
David Lockley has made significant contributions to the field of toxicology through his leadership roles and expertise. He chairs the Cefic Titanium Dioxide Manufacturers Association (TDMA) Scientific Committee and leads the TiO2 CLH Task Force, focusing on regulatory interactions. His work involves providing toxicological expertise to various industry consortia and trade associations, enhancing human health research and risk assessment practices.